“caltech” Archives

in
Entry Author Date Location
Tech Ethics, Regulation & Strategy: Here’s the Napa Summit Agenda 05/10/19 National
Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs 03/20/17 Boston
Cerulean’s Shares Routed as Cancer Drug Comes up Short Again 08/17/16 Boston
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Clinical Trial Innovation Prize Backs Ideas Using Health Records, Apps 08/11/15 Wisconsin
The Near Death, and Second Life, of Cerulean Pharma 07/13/15 Boston
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
Facebook Boston Looks to Build Tech for the “Next Few Billion Users” 05/22/14 Boston
Indi Reels In $47M To Push Launch Of Lung Cancer Diagnostic 04/29/14 Seattle
Minerva’s Plan to Disrupt Universities: A Talk with CEO Ben Nelson 04/18/14 National
Brushing Off Clinical Setback, Cerulean Tees Up $75M IPO 03/10/14 Boston
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
InDi Spinoff Gets $1.5M, Aims to Beat Antibodies in Diagnostics 09/20/13 Seattle
Coursera Receives $43,000,000 Series B Funding Round 07/10/13 San Francisco
Cerulean Pharma Fails to Extend Lives in Lung Cancer Study 03/22/13 Boston
Allozyne Conducts Round of Employee ‘Furloughs’ 03/15/13 Seattle
Cerulean Pharma Arrives at Turning Point With Cancer Drug 03/06/13 Boston
Bill Gates Turns His Attention, and Money, to Toilet Innovation 08/15/12 Seattle
Allan Jones, the Force Behind Paul Allen’s Vision for Brain Science 07/26/12 Seattle
Coursera Secures $3,700,000 Series A Funding Round 07/18/12 San Francisco
A Computer Guy’s Dream, Immusoft, Turns Cells Into Drug Factories 07/05/12 Seattle
InDi Unit Looks to Take PET Imaging ‘From Black & White to Technicolor’ 06/13/12 Seattle
Leftronic Turns Any Startup Office into a Command Center 06/04/12 San Francisco
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Paul Allen Commits $300M to Expand Institute for Brain Science 03/21/12 Seattle
InDi, Lee Hood’s Vision for Spotting Cancer in Blood, Snags $10M 02/22/12 Seattle
Xconomist of the Week: Stephen Wolfram on Big Ideas & Companies 12/08/11 Boston
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ 06/22/11 Seattle
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News 03/24/11 Seattle
Allen Institute Adds Caltech Neuroscientist 03/22/11 Seattle
Page 1 of 3 next page »